Texas Permanent School Fund’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-28,541
Closed -$1.11M 307
2024
Q1
$1.11M Buy
28,541
+369
+1% +$12.9K 0.01% 1296
2023
Q4
$867K Sell
28,172
-1,327
-4% -$33.2K 0.01% 1338
2023
Q3
$659K Sell
29,499
-961
-3% -$21.9K 0.01% 1370
2023
Q2
$655K Buy
30,460
+353
+1% +$8.01K 0.01% 1383
2023
Q1
$722K Buy
30,107
+8,215
+38% +$218K 0.01% 1335
2022
Q4
$508K Sell
21,892
-2,516
-10% -$50.7K 0.01% 1343
2022
Q3
$391K Sell
24,408
-70
-0.3% -$1.23K 0.01% 1402
2022
Q2
$434K Sell
24,478
-30
-0.1% -$505 0.01% 1388
2022
Q1
$499K Sell
24,508
-411
-2% -$7.76K 0.01% 1390
2021
Q4
$465K Sell
24,919
-1,389
-5% -$27.1K 0.01% 1425
2021
Q3
$519K Buy
26,308
+40
+0.2% +$865 0.01% 1406
2021
Q2
$621K Buy
26,268
+302
+1% +$6.98K 0.01% 1369
2021
Q1
$615K Buy
+25,966
New +$617K 0.01% 1361

Other funds holding COLL

Texas Permanent School Fund's COLL Position: Q2 2024 in Review

Texas Permanent School Fund sold out of Collegium Pharmaceutical (COLL) in Q2 2024, closing a stake of 28,541 shares — an estimated $1.11M sold.

Texas Permanent School Fund first reported a position in COLL in Q1 2021 and held it in 13 quarters. The position peaked at $1.11M in Q1 2024. 229 funds tracked by Wall St. Rank hold COLL as of Q2 2024.

  • Texas Permanent School Fund reported no remaining Collegium Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Texas Permanent School Fund sold 28,541 Collegium Pharmaceutical shares in Q2 2024, an estimated $1.11M.
  • Texas Permanent School Fund first reported a position in Collegium Pharmaceutical in Q1 2021 and held it in 13 quarters.
  • Texas Permanent School Fund's Collegium Pharmaceutical position peaked at $1.11M in Q1 2024.
  • 229 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.